Related references
Note: Only part of the references are listed.Molecular insights into psychedelic drug action
Samuel T. Slocum et al.
JOURNAL OF NEUROCHEMISTRY (2022)
Molecular targets of psychedelic-induced plasticity
Alaina M. Jaster et al.
JOURNAL OF NEUROCHEMISTRY (2022)
The evolution of the psychedelic revolution
Lindsay P. Cameron et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology
Genis Ona et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants
Ronald S. Duman et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Hewa Artin et al.
WORLD JOURNAL OF PSYCHIATRY (2021)
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig
Lene Lundgaard Donovan et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Nakul Ravi Raval et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra et al.
PHARMACOLOGICAL REVIEWS (2021)
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Danilo De Gregorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia et al.
TRENDS IN NEUROSCIENCES (2021)
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga et al.
CELL REPORTS (2021)
Convergence of distinct signaling pathways on synaptic scaling to trigger rapid antidepressant action
Kanzo Suzuki et al.
CELL REPORTS (2021)
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Eero Castren et al.
BIOLOGICAL PSYCHIATRY (2021)
Psychedelic-inspired drug discovery using an engineered biosensor
Chunyang Dong et al.
CELL (2021)
The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex
Lynette A. Desouza et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Serotonergic Psychedelics in Neural Plasticity
Kacper Lukasiewicz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas et al.
FRONTIERS IN PSYCHIATRY (2021)
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M. Mitchell et al.
NATURE MEDICINE (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Catalysts for change: the cellular neurobiology of psychedelics
Matthew I. Banks et al.
MOLECULAR BIOLOGY OF THE CELL (2021)
An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress
Ju Lu et al.
MOLECULAR PSYCHIATRY (2021)
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao et al.
NEURON (2021)
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
Ramona M. Rodriguiz et al.
SCIENTIFIC REPORTS (2021)
Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth
Calvin Ly et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects
David B. Yaden et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
Marianna Crispino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies
Lee E. Dunlap et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions
Brendan D. Hare et al.
MOLECULAR PSYCHIATRY (2020)
Tripping on nothing: placebo psychedelics and contextual factors
Jay A. Olson et al.
PSYCHOPHARMACOLOGY (2020)
The Role of BDNF on Neural Plasticity in Depression
Yang Tao et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome
Reid H. J. Olsen et al.
NATURE CHEMICAL BIOLOGY (2020)
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT2A receptor
Antara A. Banerjee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders
Ege T. Kavalali et al.
NEURON (2020)
Interclass GPCR heteromerization affects localization and trafficking
Rudy Toneatti et al.
SCIENCE SIGNALING (2020)
Site-Specific Incorporation of Genetically Encoded Photo-Crosslinkers Locates the Heteromeric Interface of a GPCR Complex in Living Cells
Urjita H. Shah et al.
CELL CHEMICAL BIOLOGY (2020)
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Terakado Kimura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins
Aintzane Garcia-Bea et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation
R. N. Moda-Sava et al.
SCIENCE (2019)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine
Sriparna Ghosal et al.
BIOLOGICAL PSYCHIATRY (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity
Ido Hartogsohn
FRONTIERS IN NEUROSCIENCE (2018)
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Katrin H. Preller et al.
ELIFE (2018)
Psychedelics as Medicines: An Emerging New Paradigm
D. E. Nichols et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers
Imane Moutkine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons
Luisa Speranza et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Neuronal plasticity and neurotrophic factors in drug responses
E. Castren et al.
MOLECULAR PSYCHIATRY (2017)
Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
Eero Castren et al.
NEUROBIOLOGY OF DISEASE (2017)
Receptor-stimulated transamidation induces activation of Rac1 and Cdc42 and the regulation of dendritic spines
Zhen Mi et al.
NEUROPHARMACOLOGY (2017)
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Robin L. Carhart-Harris et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Psychedelic Drugs in Biomedicine
Evan J. Kyzar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
Vanja Dakic et al.
SCIENTIFIC REPORTS (2017)
The prefrontal cortex as a critical gate of negative affect and motivation in alcohol use disorder
Amanda R. Pahng et al.
CURRENT OPINION IN BEHAVIORAL SCIENCES (2017)
Magnetic resonance imaging structural alterations in brain of alcohol abusers and its association with impulsivity
Samuel Asensio et al.
ADDICTION BIOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
Ido Hartogsohn
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
BDNF - a key transducer of antidepressant effects
Carl Bjorkholm et al.
NEUROPHARMACOLOGY (2016)
Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
David A. Martin et al.
EBIOMEDICINE (2016)
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2016)
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2016)
Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex
Victoria Phoumthipphavong et al.
ENEURO (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
In Vivo AAV1 Transduction With hRheb(S16H) Protects Hippocampal Neurons by BDNF Production
Min-Tae Jeon et al.
MOLECULAR THERAPY (2015)
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
Xavier Vinals et al.
PLOS BIOLOGY (2015)
The effects of stress exposure on prefrontal cortex: Translating basic research into successful treatments for post-traumatic stress disorder
Amy F. T. Arnsten et al.
NEUROBIOLOGY OF STRESS (2015)
Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280 by Hallucinogenic versus Nonhallucinogenic Agonists
Samah Karaki et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Serotonin 2A receptor regulates microtubule assembly and induces dynamics of dendritic growth cones in rat cortical neurons in vitro
Akiko Ohtani et al.
NEUROSCIENCE RESEARCH (2014)
5-HT6 receptor antagonists as treatment for age-related cognitive decline
Anne Quiedeville et al.
REVIEWS IN THE NEUROSCIENCES (2014)
Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative
Alfredo Meneses
REVIEWS IN THE NEUROSCIENCES (2014)
Animal Models of Serotonergic Psychedelics
James B. Hanks et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
Bhavya Voleti et al.
BIOLOGICAL PSYCHIATRY (2013)
Gray Matter Correlates of Posttraumatic Stress Disorder: A Quantitative Meta-Analysis
Simone Kuehn et al.
BIOLOGICAL PSYCHIATRY (2013)
The two faces of the pharmacological interaction of mGlu2 and 5-HT2A - Relevance of receptor heterocomplexes and interaction through functional brain pathways
Hannah K. Delille et al.
NEUROPHARMACOLOGY (2013)
Structural Features for Functional Selectivity at Serotonin Receptors
Daniel Wacker et al.
SCIENCE (2013)
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Briony J. Catlow et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Caroline A. Browne et al.
FRONTIERS IN PHARMACOLOGY (2013)
Molecular Pharmacology and Ligand Docking Studies Reveal a Single Amino Acid Difference between Mouse and Human Serotonin 5-HT2A Receptors That Impacts Behavioral Translation of Novel 4-Phenyl-2-dimethylaminotetralin Ligands
Clinton E. Canal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
Rong-Jian Liu et al.
BIOLOGICAL PSYCHIATRY (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs
Miguel Fribourg et al.
CELL (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Rita Z. Goldstein et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
Jose L. Moreno et al.
NEUROSCIENCE LETTERS (2011)
Subtype specific roles of serotonin receptors in the spine formation of cortical neurons in vitro
Hiroyuki Yoshida et al.
NEUROSCIENCE RESEARCH (2011)
Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
Sylwia Lukasiewicz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Differences in the C-terminus contribute to variations in trafficking between rat and human 5-HT2A receptor isoforms: identification of a primate-specific tripeptide ASK motif that confers GRK-2 and β arrestin-2 interactions
Aditi Bhattacharya et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo
Cullen L. Schmid et al.
JOURNAL OF NEUROSCIENCE (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
The 5-HT2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines
T. Oufkir et al.
PLACENTA (2010)
The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen
Clinton E. Canal et al.
PSYCHOPHARMACOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
Atheir I. Abbas et al.
JOURNAL OF NEUROSCIENCE (2009)
Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
Hussam Jourdi et al.
JOURNAL OF NEUROSCIENCE (2009)
Posttraumatic Stress Disorder: The Role of Medial Prefrontal Cortex and Amygdala
Michael Koenigs et al.
NEUROSCIENTIST (2009)
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
Kelly A. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Serotonin receptors
David E. Nichols et al.
CHEMICAL REVIEWS (2008)
Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells
Didier Cussac et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
Neil Upton et al.
NEUROTHERAPEUTICS (2008)
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Cullen L. Schmid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane
Efrain E. Garcia et al.
NEUROPHARMACOLOGY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex
HS Crombag et al.
CEREBRAL CORTEX (2005)
Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex
Q Pei et al.
NEUROPHARMACOLOGY (2004)
Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gαq-coupled protein receptors
A Bhatnagar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-β and ILAD-1, a novel gene with homology to arrestins
CD Nichols et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Structural plasticity associated with exposure to drugs of abuse
TE Robinson et al.
NEUROPHARMACOLOGY (2004)
Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites
N Takei et al.
JOURNAL OF NEUROSCIENCE (2004)
Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
JW Muschamp et al.
BRAIN RESEARCH (2004)
A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation:: the involvement of MAP kinases
DM Kurrasch-Orbaugh et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT2A receptor induces agonist-independent internalization
JA Gray et al.
MOLECULAR PHARMACOLOGY (2003)
Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
CD Nichols et al.
MOLECULAR BRAIN RESEARCH (2003)
Serotonin 5-hydroxytryptamine(2A) receptor-coupled phospholipase C and phospholipase A(2) signaling pathways have different receptor reserves
DM Kurrasch-Orbaugh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain
PS Frankel et al.
BRAIN RESEARCH (2002)
Role of dopamine, the frontal cortex and memory circuits in drug addiction: Insight from imaging studies
ND Volkow et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2002)
Re-evaluation of lisuride pharmacology:: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats
D Marona-Lewicka et al.
PSYCHOPHARMACOLOGY (2002)
Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex
RZ Goldstein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors
JC Gewirtz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens
RA Rabin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain
CD Nichols et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Lysergic acid diethylamide-induced Fos expression in rat brain: Role of serotonin-2A receptors
PJ Gresch et al.
NEUROSCIENCE (2002)
Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites
Q Pei et al.
NEUROPHARMACOLOGY (2000)
Share Paper
